

(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026.


Avacta Group PLC - London-based clinical-stage biopharmaceutical company - Raises gross proceeds of approximately GBP9 million from institutional inve...


(Sharecast News) - Avacta announced on Friday that it had raised about £9m through an oversubscribed placing with institutional investors and exi...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...


(Sharecast News) - Avacta Group said on Tuesday that it had strengthened its position as a pure-play oncology biopharmaceutical company during 2025, w...


(Alliance News) - Avacta Group PLC on Tuesday said clinical data from two cancer trials is expected to be released this year as it reported a widened ...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued last Wednesday and not separately reported by Alliance New...